Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CCND1 silencing suppresses liver cancer stem cell differentiation and overcomes 5-Fluorouracil resistance in hepatocellular carcinoma
Hao Ding, Yijun Wang, Hongying Zhang
Journal of Pharmacological Sciences (2020) Vol. 143, Iss. 3, pp. 219-225
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Sepideh Mirzaei, Ali Zarrabi, Farid Hashemi, et al.
Cancer Letters (2021) Vol. 509, pp. 63-80
Closed Access | Times Cited: 193
Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation
Jing Wang, Wei Su, Taotao Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 43
Study of Characterization, Antimicrobial, and Anticancer Potential of Albumin-Baicalin Nanoparticles in Hep3B Liver Cancer Cell Lines
Baby Shakila, Sulaiman Ali Alharbi, Tahani Awad Alahmadi, et al.
BioNanoScience (2025) Vol. 15, Iss. 1
Closed Access | Times Cited: 2
DNA‐Damage‐Response‐Targeting Mitochondria‐Activated Multifunctional Prodrug Strategy for Self‐Defensive Tumor Therapy
Paramesh Jangili, Na Kong, Ji Hyeon Kim, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 16
Closed Access | Times Cited: 47
Gallic acid ameliorates endometrial hyperplasia through the inhibition of the PI3K/AKT pathway and the down-regulation of cyclin D1 expression
Caijie Zheng, Yi Wang, Beilei Bi, et al.
Journal of Pharmacological Sciences (2024) Vol. 155, Iss. 1, pp. 1-13
Open Access | Times Cited: 7
Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer
Po-Shuan Huang, Ling‐Yu Wang, Yiwen Wang, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 869-869
Open Access | Times Cited: 15
Nanomedicines for hepatocellular carcinoma therapy: Challenges and clinical applications
Mahsa Sedighi, Zahra Mahmoudi, Samin Abbaszadeh, et al.
Materials Today Communications (2023) Vol. 34, pp. 105242-105242
Open Access | Times Cited: 13
Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of Cnidium monnieri in Treating Hepatocellular Carcinoma
Shakeel Ahmad Khan, Terence K. Lee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5400-5400
Open Access | Times Cited: 22
Knockdown of circ_0004585 enhances the chemosensitivity of colorectal cancer cells to 5-fluorouracil via the miR-874-3p/CCND1 axis.
Shijie Wang, Juan Cao, Lijuan Pei
PubMed (2023) Vol. 38, Iss. 1, pp. 99-112
Closed Access | Times Cited: 9
Targeting the mechano-microenvironment and liver cancer stem cells: a promising therapeutic strategy for liver cancer
Xiaorong Fu, Yi Zhang, Qing Luo, et al.
Cancer Biology and Medicine (2023), pp. 1-14
Open Access | Times Cited: 9
MAT1A activation of glycolysis to promote NSCLC progression depends on stabilizing CCND1
Shengping Shen, Ruili Liu, Jiazheng Huang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 3
Long Non-coding RNA LINC00342 Promotes the Proliferation, Invasion, and Migration of Primary Hepatocellular Carcinoma Cells by Regulating the Expression of miRNA-19a-3p, miRNA-545-5p, and miRNA-203a-3p
Zong-Xi Yao, Junhao Tu, Yulin Liu, et al.
Biochemical Genetics (2023) Vol. 62, Iss. 2, pp. 675-697
Closed Access | Times Cited: 7
New insights into aflatoxin B1 mechanistic toxicology in cattle liver: an integrated approach using molecular docking and biological evaluation in CYP1A1 and CYP3A74 knockout BFH12 cell lines
Silvia Iori, Maija Lahtela‐Kakkonen, Caterina D’Onofrio, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 3097-3108
Open Access | Times Cited: 2
Targeting Hepatic Cancer Stem Cells (CSCs) and Related Drug Resistance by Small Interfering RNA (siRNA)
Saade Abdalkareem Jasim, Omar Dheyauldeen Salahdin, H. Malathi, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3031-3051
Closed Access | Times Cited: 2
Effects of Biofilm Nano-Composite Drugs OMVs-MSN-5-FU on Cervical Lymph Node Metastases From Oral Squamous Cell Carcinoma
Jian Huang, Zhiyuan Wu, Junwu Xu
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Effect of Shan Zha (Hawthorn or Crataegus) on gastrointestinal cancer: A network pharmacology and molecular docking study
Jing Yang, Jialin Gu, Ying Shen, et al.
Cancer Pathogenesis and Therapy (2023) Vol. 1, Iss. 4, pp. 229-237
Open Access | Times Cited: 6
Wogonin Induces Cell Cycle Arrest and Apoptosis of Hepatocellular Carcinoma Cells by Activating Hippo Signaling
Yanbing Ding, Weigan Shen, Keyan Wu, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 8, pp. 1551-1560
Closed Access | Times Cited: 13
Integration of Adverse Outcome Pathways, Causal Networks and ‘Omics to Support Chemical Hazard Assessment
Edward J. Perkins, Alice Woolard, Natàlia García‐Reyero
Frontiers in Toxicology (2022) Vol. 4
Open Access | Times Cited: 9
Decoding the mechanism of andrographolide to combat hepatocellular carcinoma: a network pharmacology integrated molecular docking and dynamics approach
Nandan Dixit, Harsha Motwani, Saumya Patel, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 19, pp. 10237-10255
Closed Access | Times Cited: 5
Current perspectives on exosomes in the diagnosis and treatment of hepatocellular carcinoma (review)
Dongdong Xue, Jingzhao Han, Yifan Liu, et al.
Cancer Biology & Therapy (2021) Vol. 22, Iss. 4, pp. 279-290
Open Access | Times Cited: 12
DNA‐Damage‐Response‐Targeting Mitochondria‐Activated Multifunctional Prodrug Strategy for Self‐Defensive Tumor Therapy
Paramesh Jangili, Na Kong, Ji Hyeon Kim, et al.
Angewandte Chemie (2022) Vol. 134, Iss. 16
Closed Access | Times Cited: 8
Radiomic Prediction of CCND1 Expression Levels and Prognosis in Low-grade Glioma Based on Magnetic Resonance Imaging
Kun Zhao, Hui Zhang, Jianyang Lin, et al.
Academic Radiology (2024) Vol. 31, Iss. 11, pp. 4595-4610
Open Access | Times Cited: 1
Schisandra chinensis Bee Pollen Extract Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells via Ferroptosis-, Wnt-, and Focal Adhesion–Signaling Pathways
Zhiliang Li, Jiali Yang, Yang Sun, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2745-2760
Open Access | Times Cited: 1
Anlotinib exerts anti‐cancer efficiency on lung cancer stem cells in vitro and in vivo through reducing NF‐κB activity
Zhuohong Li, Juncai Tian, Lei Du, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 12, pp. 5547-5559
Open Access | Times Cited: 10
Spiromesifen contributes vascular developmental toxicity via disrupting endothelial cell proliferation and migration in zebrafish embryos
Mingxing Wang, Juan Liu, Hui‐Yun Wang, et al.
Pesticide Biochemistry and Physiology (2022) Vol. 188, pp. 105242-105242
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top